Russell Investments Group
ADPT icon

Russell Investments Group’s Adaptive Biotechnologies ADPT Stock Holding History

Russell Investments Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
78,722
-195,694
-71% -$3M ﹤0.01% 2176
2026
Q1 		$3.81M Sell
274,416
-177,791
-39% -$2.83M ﹤0.01% 1510
2025
Q4 		$7.34M Buy
452,207
+67,497
+18% +$1.1M 0.01% 1085
2025
Q3 		$5.76M Sell
384,710
-204,901
-35% -$2.5M 0.01% 1225
2025
Q2 		$6.87M Buy
589,611
+423,780
+256% +$3.85M 0.01% 1036
2025
Q1 		$1.23M Buy
165,831
+84,837
+105% +$652K ﹤0.01% 1940
2024
Q4 		$486K Buy
80,994
+2,163
+3% +$11.9K ﹤0.01% 2277
2024
Q3 		$404K Buy
78,831
+76,069
+2,754% +$331K ﹤0.01% 2337
2024
Q2 		$10K Buy
+2,762
New +$8.77K ﹤0.01% 3076
2024
Q1 		– Sell
-81,595
Closed -$400K – 3301
2023
Q4 		$400K Buy
81,595
+60,055
+279% +$274K ﹤0.01% 2290
2023
Q3 		$117K Sell
21,540
-76,881
-78% -$508K ﹤0.01% 2594
2023
Q2 		$660K Buy
98,421
+1,021
+1% +$7.59K ﹤0.01% 2125
2023
Q1 		$860K Buy
+97,400
New +$859K ﹤0.01% 2047
2020
Q2 		– Sell
-3,145
Closed -$85K – 3114
2020
Q1 		$85K Sell
3,145
-305
-9% -$8.51K ﹤0.01% 2773
2019
Q4 		$99K Buy
+3,450
New +$99.1K ﹤0.01% 2886

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Russell Investments Group's ADPT Position: Q2 2026 in Review

Russell Investments Group reduced its Adaptive Biotechnologies (ADPT) stake by 71% in Q2 2026, selling an estimated $3M and leaving 78,722 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Russell Investments Group first reported a position in ADPT in Q4 2019 and has held it in 15 quarters since. The position peaked at $7.34M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Russell Investments Group held 78,722 shares of Adaptive Biotechnologies worth $1.69M as of Q2 2026.
  • Russell Investments Group sold 195,694 Adaptive Biotechnologies shares in Q2 2026, an estimated $3M.
  • Adaptive Biotechnologies made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2176 holding.
  • Russell Investments Group first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 15 quarters since.
  • Russell Investments Group's Adaptive Biotechnologies position peaked at $7.34M in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.